As found in this study, the development of the manifest forms of diphtheria occurred in the presence of lower levels of antitoxic antibodies, than bacterial carrier state. The level of antitoxic antibodies in all patients, irrespective of the time of their examination, was higher than that of antibacterial antibodies. In the dynamics of the disease a considerable increase in antitoxic and antibacterial antibodies was observed in localized and disseminated forms of diphtheria and, to a considerably lesser degree, in toxic and subtoxic forms of diphtheria, while not observed in the process of the formation of bacterial carrier state. The dynamics of a rise in the levels of antitoxic and antibacterial antibodies in the manifest forms of diphtheria infection made it possible to differentiate between the cases of toxigenic Corynebacterium diphtheriae carrier state and those of the disease.

Download full-text PDF

Source

Publication Analysis

Top Keywords

forms diphtheria
16
antitoxic antibacterial
12
carrier state
12
antibacterial antibodies
12
manifest forms
8
levels antitoxic
8
antitoxic antibodies
8
bacterial carrier
8
antibodies
5
[characteristics antitoxic
4

Similar Publications

Prokaryotic heme biosynthesis in Gram-positive bacteria follows the coproporphyrin-dependent heme biosynthesis pathway. The last step in this pathway is catalyzed by the enzyme coproheme decarboxylase, which oxidatively transforms two propionate groups into vinyl groups yielding heme b. The catalytic reaction cycle of coproheme decarboxylases exhibits four different states: the apo-form, the substrate (coproheme)-bound form, a transient three-propionate intermediate form (monovinyl, monopropionate deuteroheme; MMD), and the product (heme b)-bound form.

View Article and Find Full Text PDF

Aneurysm Is Restricted by CD34 Cell-Formed Fibrous Collars Through the PDGFRb-PI3K Axis.

Adv Sci (Weinh)

December 2024

Department of Cardiology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China.

Aortic aneurysm is a life-threatening disease caused by progressive dilation of the aorta and weakened aortic walls. Its pathogenesis involves an imbalance between connective tissue repair and degradation. CD34 cells comprise a heterogeneous population that exhibits stem cell and progenitor cell properties.

View Article and Find Full Text PDF

Repurposing FDA-approved disulfiram for targeted inhibition of diphtheria toxin and the binary protein toxins of and .

Front Pharmacol

September 2024

Institute of Experimental and Clinical Pharmacology, Toxicology and Pharmacology of Natural Products, Ulm University Medical Center, Ulm, Germany.

Article Synopsis
  • Many bacteria release AB-type protein toxins that disrupt cell functions, causing illness; targeting these toxins could lead to new treatments.
  • The FDA-approved drug disulfiram (DSF), typically used for alcohol dependence, shows potential in protecting cells from various toxins at low concentrations.
  • DSF appears to inhibit the translocation of toxic A subunits into cells without significantly affecting toxin binding or activity.
View Article and Find Full Text PDF

The looming stimulus-evoked flight response to approaching predators is a defensive behavior in most animals. However, how looming stimuli are detected in the retina and transmitted to the brain remains unclear. Here, we report that a group of GABAergic retinal ganglion cells (RGCs) projecting to the superior colliculus (SC) transmit looming signals from the retina to the brain, mediating the looming-evoked flight behavior by releasing GABA.

View Article and Find Full Text PDF

Alpha-1 antitrypsin inhibits Clostridium botulinum C2 toxin, Corynebacterium diphtheriae diphtheria toxin and B. anthracis fusion toxin.

Sci Rep

September 2024

Institute of Experimental and Clinical Pharmacology, Toxicology and Pharmacology of Natural Products, Ulm University Medical Center, 89081, Ulm, Germany.

Article Synopsis
  • The bacterium Clostridium botulinum produces C2 toxin, which is a binary AB-toxin that disrupts the cytoskeleton of cells, leading to cell death.
  • C2 toxin consists of an active A-component (C2I) and a binding B-component (C2II), which together enter cells and mediate their toxic effects by ADP-ribosylating G-actin.
  • The serine-protease inhibitor α-antitrypsin (αAT) can inhibit the effects of C2 toxin and other toxins, suggesting its potential repurposing as a treatment for diseases caused by these toxins.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!